BDBM50133065 17,20,23,26,29-pentaoxa-4,14,32-triazahexacyclo[30.6.1.17,14.02,6.08,13.033,38]tetraconta-1(39),2(6),7(40),8,10,12,33,35,37-nonaene-3,5-dione::CHEMBL130774

SMILES O=C1NC(=O)C2=C1c1cn(CCOCCOCCOCCOCCOCCn3cc2c2ccccc32)c2ccccc12

InChI Key InChIKey=QLNNQGZYMRYENG-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50133065   

TargetProtein kinase C gamma type(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50133065(17,20,23,26,29-pentaoxa-4,14,32-triazahexacyclo[30...)
Affinity DataIC50:  5.17E+3nMAssay Description:Inhibition of Protein kinase C gamma (PKC-gamma)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50133065(17,20,23,26,29-pentaoxa-4,14,32-triazahexacyclo[30...)
Affinity DataIC50:  51nMAssay Description:Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed